CPHI vs EG · rev $4.1M vs P/E 17, rev $17.28B
China Pharma Holdings Inc (CPHI) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
CPHI currently screens at market cap $29.0M. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the CPHI and EG stock pages for the full models.
Not investment advice.